FISPB
OLMA icon

Fideuram - Intesa Sanpaolo Private Banking’s Olema Pharmaceuticals OLMA Stock Holding History

Fideuram - Intesa Sanpaolo Private Banking’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Buy
161,836
+45,024
+39% +$603K 0.06% 229
2026
Q1 		$1.74M Buy
116,812
+113,312
+3,237% +$2.52M 0.06% 239
2025
Q4 		$87.5K Buy
+3,500
New +$62.3K ﹤0.01% 367

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking's OLMA Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking increased its Olema Pharmaceuticals (OLMA) stake by 39% in Q2 2026, buying an estimated $603K and bringing the position to 161,836 shares worth $2.02M. The position accounts for 0.06% of the portfolio, ranked #229.

Fideuram - Intesa Sanpaolo Private Banking first reported a position in OLMA in Q4 2025 and has held it in 3 quarters since. 184 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Fideuram - Intesa Sanpaolo Private Banking held 161,836 shares of Olema Pharmaceuticals worth $2.02M as of Q2 2026.
  • Fideuram - Intesa Sanpaolo Private Banking bought 45,024 Olema Pharmaceuticals shares in Q2 2026, an estimated $603K.
  • Olema Pharmaceuticals made up 0.06% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #229 holding.
  • Fideuram - Intesa Sanpaolo Private Banking first reported a position in Olema Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 184 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.